Circon board asks shareholders to defer decision on U.S. Surgical tender bid.
This article was originally published in The Gray Sheet
Executive Summary
CIRCON ASKS SHAREHOLDERS TO DEFER DECISION ON U.S. SURGICAL OFFER "until they have been advised of Circon's position" on the unsolicited $18-per-share tender bid. In an Aug. 5 press release, Circon says its board of directors "is currently conferring with its financial and legal advisors" about the offer launched Aug. 2 ("The Gray Sheet" Aug. 5, p. 3) and will respond "in due course in accordance with its obligations under the securities laws."